India  
NewsR.in
"Sun Pharma" News 
0
shares
ShareTweetSavePostSend
 

Sensex up 404 points, ends 9-day losing streak

On the BSE index, Tata Steel, Vendata, ONGC, NTPC, Yes Bank, Infosys, SBI and Sun Pharma were among the major gainers with their stocks rising as much as 4.78%. Of the 30 Sensex constituents, 25 closed..
IndiaTimes - Published

Sensex soars over 250 points; metal stocks rally

Top gainers in the Sensex pack include ONGC, Vedanta, Yes Bank, Bajaj Finance, Axis Bank, Sun Pharma, L&T, Tata Steel, HDFC, Reliance and Bharti Airtel, rising up to 2.12 per cent. On the other hand,..
IndiaTimes - Published

Sensex crashes 311 points to end below 35,500-mark; Nifty at 10,641

On the BSE index, Tata Consultancy Services, Yes Bank, Reliance Industries, ITC, Sun Pharma, Coal India and Asian Paints were among the worst performers with their stocks down as much as 3.02 per cent...
IndiaTimes - Published

Sun Pharma, Ajanta Pharma may trade positive today

Nifty 50 has strong multi-month support at 10580-10600 levels, which is the last month low. Below these levels, we expect a sharp profit booking across sectors and stocks
DNA - Published

Sun Pharma Q3 profit zooms nearly 4-fold to Rs 1,241.85 crore

The company had posted a net profit of Rs 321.57 crore for the corresponding period of the previous fiscal hit by one-time deferred tax adjustment.
Zee News - Published Also reported by •Firstpost

Sun Pharma reports 49% jump in net profit at Rs 1,242 crore during Q3

Sun Pharmaceutical Industries has registered gross sales of Rs 7,657 crore in the quarter ending December 2018, marking 16 per cent growth over the same quarter of previous
Sify - Published

Sun Pharma's net profit zooms nearly four-fold to Rs 1,242 cr in December quarter; shares up 2%

Drug major Sun Pharmaceutical Industries Tuesday reported a nearly four-fold jump in its consolidated net profit at Rs 1,241.85 crore for the quarter ended 31 December, 2018
Firstpost - Published

Sun Pharma third-quarter profit jumps four-fold on strong U.S. show

India's largest drugmaker by market value Sun Pharmaceutical Industries Ltd posted a nearly four-fold jump in quarterly profit on Tuesday, breezing past estimates on strong sales in the U.S. market.
Reuters India - Published

Sun Pharma third-quarter profit rises nearly four-fold, beats estimate

Sun Pharmaceutical Industries Ltd, India's largest drugmaker by market value, posted a nearly four-fold jump in quarterly profit on Tuesday, beating estimates.
Reuters India - Published

Sensex jumps 150 points, Nifty rises over 30 points ahead of RBI policy outcome; Sun Pharma, Bajaj Auto, HCL Tech among top gainers

Sensex was trading 161.53 points, or 0.44 percent, higher at 37,136.76. NSE Nifty rose 33.05 points, or 0.30 percent to 11,095.50.
Firstpost - Published

Markets reverse two-day losing streak, end higher

Meanwhile, Tata Motors, Sun Pharma, Coal India and Bajaj Auto were the top losers that capped the gains, falling up to 2.27 percent.
Zee News - Published

Sun Pharma shares rebound 6% on damage control

Sun Pharma says it "would like to dispel all falsehood" spread about its financial dealings with Suraksha Realty
DNA - Published

Sun Pharma shares pledged to raise fund for Suraksha; realty firm uses same method thrice in past two years for money

Shanghvi Finance, which is a major shareholder in Sun Pharma, pledged a portion of its stake in India's largest drugmaker to facilitate Suraksha Realty for raising Rs 100 crore through commercial..
Firstpost - Published

Sun Pharma takes steps to ease governance concerns; shares rally

India's top drugmaker by market value Sun Pharmaceutical Industries announced on Tuesday a new local distributor and other measures in a bid to ease investor concerns over its corporate governance,..
Reuters India - Published

Sun Pharma shares rise 6% as company replaces domestic formulations distributor with its own subsidiary

Shares of Sun Pharmaceuticals on Tuesday surged over 6 percent after it replaced its domestic formulations distributor Aditya Medisales with its own subsidiary in the backdrop of a second whistleblower..
Firstpost - Published

Sun Pharma replaces formulations distributor with own unit

Indian drugmaker Sun Pharmaceutical Industries Ltd said on Tuesday it will make its unit the new distributor for its domestic formulations business, replacing Aditya Medisales Ltd.
Reuters India - Published

Sun Pharma to make unit distributor for local formulations biz

Indian drugmaker Sun Pharmaceutical Industries Ltd said on Tuesday it will make its unit the new distributor for its domestic formulations business, replacing Aditya Medisales.
Reuters India - Published

Sun Pharma ends 2% higher on Sensex

After a heavy sell-off by the end of last week, stocks of Sun Pharma closed nearly 2 per cent higher on Monday after the company claimed the reports against it of unfair business practices were..
Sify - Published

Sun Pharma shares rise 2% as company seeks SEBI intervention in unfair business practices

Shares of Sun Pharmaceutical Industries surged 2 percent on Monday as it sought SEBI's intervention in the issue of alleged unfair business practices against the company
Firstpost - Published

Sensex jumps over 200 points; Nifty above 10,950

Reliance Industries, Sun Pharma, Infosys, Bajaj Finance, HDFC Bank and Bharti Airtel were among the top trading stocks on the BSE platform with their stocks rising as much as 2,75 per cent. On NSE,..
IndiaTimes - Published

Sun Pharma stock rebounds, jumps 4%

Pharmaceutical major Sun Pharma's stock gained 4 per cent to touch a high of Rs 406.35 on Monday after it ended Friday's trade lower at more than 8 per cent.
Sify - Published

Sun Pharma stocks plunge on revelation of whistleblower's complaint

The stock of pharmaceutical major Sun Pharma ended up as the top loser on the BSE Sensex on Friday following reports of a complaint by a whistleblower to the Securities and Exchange Board of India..
Sify - Published Also reported by •Reuters India

Sensex ends flat amid Sun Pharma woes, easing trade concerns

Heavy sell-off in the healthcare stocks led by Sun Pharmaceuticals kept the key equity indices subdued for most part of the Friday's trading session, before positive global markets helped them recover..
Sify - Published

Sun Pharma asks SEBI to examine media report

Sun Pharmaceutical Industries Ltd on Friday asked India's capital markets regulator to look into a media report about an alleged complaint by a whistleblower that led to a sell-off in the company's..
Reuters India - Published

Sun Pharma writes to SEBI over whistleblower complaint, says certain entities doing unfair biz practices against it

In November 2018, a whistleblower approached Sebi with a document alleging various irregularities by the company, its promoter and others.
Zee News - Published

Sun Pharma shares crash over 13% amid reports of fresh whistleblower complaint against company

The scrip after a weak opening further tumbled 12.11 percent to hit a multi-year low of Rs 375.40 on BSE.
Firstpost - Published Also reported by •Reuters India

Markets end marginally higher; RIL rallies, Sun Pharma drags

Other gainers included Kotak Bank, HCL Tech, ONGC, Asian Paints, Vedanta, HDFC Bank, Bajaj Finance, Maruti and TCS, gaining up to 1.41 percent.
Zee News - Published

Indian shares fall as allegations against Sun Pharma weigh

Indian shares fell on Friday, dragged by Sun Pharmaceutical Industries Ltd after reports of fresh allegations by a whistleblower, though gains in Reliance Industries Ltd after strong quarterly earnings..
Reuters India - Published

Sensex, Nifty start on a volatile note; Sun Pharma biggest loser among pharma stocks, tanks 10%

The Sensex settled 52.79 points or 0.15 percent higher at 36,374.08; and the broader NSE Nifty inched up 14.90 points or 0.14 percent to 10,905.20
Firstpost - Published

Sun Pharma tumbles on report of fresh allegations by whistleblower

Shares of India's Sun Pharmaceutical Industries Ltd slumped over 13 percent on Friday to near six-year low, after a media report of a complaint by a whistleblower raised fresh concerns on the..
Reuters India - Published

Markets pare gain soon after opening, Sun Pharma tanks over 10%

Asian stocks gained early on Friday, as hopes for a thaw in the US-China trade conflict fed investor appetites for risk assets.
Zee News - Published

Divis Lab, Sun Pharma, YES Bank, Cadila likely to be in focus today

Till 10627 levels are held the probability of an upward breakout from the consolidating range is quite higher
DNA - Published

Sun Pharma recalls around 14,000 cartons of anaesthesia injection from US market

Sun Pharmaceutical has said its US subsidiary has started voluntarily recalling 13,918 cartons of Vecuronium Bromide Injection of 10 mg and 20 mg strengths from US market at the hospital level,..
Firstpost - Published

Sun Pharma acquires Japan's Pola Pharma; firm eyes to expand global presence in dermatology segment

The acquisition of 100 percent shares of Pola Pharma Inc Japan by the company's wholly owned subsidiary has been concluded, Sun Pharma said in a BSE filing.
Firstpost - Published

Sun Pharma acquires Japan's Pola Pharma

The acquisition of 100 per cent shares of Pola Pharma Inc Japan by the company's wholly owned subsidiary has been concluded, Sun Pharma said in a BSE filing.
Zee News - Published

Sensex, Nifty end 2018 on a flat note

On BSE, Tata Steel, Vedanta, Sun Pharma, Tata Motors, IndusInd Bank and Kotak Mahindra Bank were among the top gainers with their stocks surging as much as 1.59 per cent. On the NSE platform, apart..
IndiaTimes - Published

Sensex ends 269 points higher, reclaims 36,000-mark; Nifty at 10,860

On the BSE index, Sun Pharma, Bajaj Finance, Vedanta, HDFC, Yes Bank and ICICI Bank were the top gainers, rising as much as 2.98 per cent. On NSE, all the sub-indices ended in green with Nifty Media..
IndiaTimes - Published

Sun Pharma arm gets relief from US court in patent infringement case

Massachusetts-based DUSA has been granted preliminary injunctive relief by a federal district court prohibiting defendants Biofrontera Inc, Biofrontera Bioscience GmbH, Biofrontera Pharma GmbH, and..
Firstpost - Published

Markets open higher, Sensex up over 80 points

On the BSE platform, Sun Pharma, Infosys, ICICI Bank and State Bank of India (SBI) were among the major gainers with their stocks surging as much as 1.39 per cent. On NSE, sub-indices Nifty Pharma and..
IndiaTimes - Published

L&T, Sun Pharma, Axis Bank may take centre stage today

The 50-share index is likely to trade with a positive bias for the target of 11150 with support pegged at 10700 levels
DNA - Published

Markets end higher for sixth straight day, Nifty above 10,900

Sun Pharma, PowerGrid, Mahindra and Mahindra, Vedanta, Asian Paints and L&T were among the major gainers on the BSE platform with their stocks rising as much as 2.98 per cent. On NSE, sub-indices Nifty..
IndiaTimes - Published

Sebi examines whistleblower complaint against Sun Pharma: All you need to know about issue plaguing drugmaker

In August 2017, Sun Pharmaceutical, Shanghvi and nine other entities settled an insider trading probe on payment of Rs 18 lakh towards settlement charges
Firstpost - Published

You Might Like


 Page 1  〉 
Environmentally friendly: newsR is hosted on servers powered solely by renewable energy
© 2019 newsR Ltd. All Rights Reserved.
About us  |  Contact us  |  Disclaimer  |  Terms & Conditions  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  In the News  |  DMCA / Content Removal  |  Privacy & Data Protection Policy
How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter  •  FOLLOW us on Pinterest